Xenocor

Salt Lake City, United States

Xenocor offers a suite of leading edge, fog-free, single-use endoscopes for minimally invasive surgical procedures.

$10.0M raised

Apr 2023

Series A

Top Investors

Mountain Pacific PartnersGenHenn VentureGrowing Impact VenturesBarancoPatel Family Investment

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Xenocor raised?

Xenocor has raised $10.0M in total funding. The most recent round was Series A. The last funding was announced in April 2023.

Who are Xenocor's investors?

Xenocor's investors include Mountain Pacific Partners, GenHenn Venture, Growing Impact Ventures, Baranco, Patel Family Investment.

Where is Xenocor headquartered?

Xenocor is headquartered in Salt Lake City, United States.

What does Xenocor do?

Xenocor offers a suite of leading edge, fog-free, single-use endoscopes for minimally invasive surgical procedures.

What stage is Xenocor at?

Xenocor is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated April 18, 2023.

MLA

"Xenocor — Funding & Investors." VCBacked, April 18, 2023, https://www.vcbacked.co/company/xenocor. Accessed June 17, 2026.

APA

VCBacked. (2023). Xenocor — Funding & Investors. Retrieved June 17, 2026, from https://www.vcbacked.co/company/xenocor

Wikipedia (cite web)

{{cite web |title=Xenocor — Funding & Investors |url=https://www.vcbacked.co/company/xenocor |website=VCBacked |access-date=June 17, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated April 18, 2023.